1.Improving the production of human placental chorionic-derived mesenchymal stem cells by modified primary culture method
Guoyi TANG ; Jieying WU ; Yan LU ; Jinsong CHEN ; Fatao LI ; Jie TANG ; Dong LIU ; Qihua LIANG ; Yan LI ; Xuewei TANG ; Guie XIE ; Shaoqing WU
International Journal of Biomedical Engineering 2017;40(3):183-187,后插4
Objective To establish a cultivating method for obtaining a large number of P0 generation human placental chorionic-derived mesenchymal stem cells (hpcMSCs).Methods The hpcMSCs were isolated from human placental chorion.After primary culturing and culturing for seven days,the culture medium,the non-adherent tissue and the douching normal saline of the primary culture were centrifuged and re-cultured twice.Cell morphology was observed by an inverted microscope.CCK-8 was used to measure the cell growth curve.Flow cytometry was used to detect cell surface markers.Adipogenic and osteogenic differentiation kits were used to assess the cell differentiation potential.Results The obtained hpcMSCs were fibroblast-like adherent cells and (25.54±3.38)×106 cells were obtained per placenta.The total yield of the primary culture,secondary culture and tertiary culture were (11.73±2.09)×106,(11.12±1.42)×106 and (2.69±0.71)×106,respectively,and the incubation time were (12.00±0.64) d,(8.87±0.63) d and (12.33±0.80) d.There was significant differences in incubation time between the secondary culture and the primary culture as well as the tertiary culture (all P<0.05),and there was no significant difference between the primary culture and the tertiary culture.However,the incubation time of the tertiary culture had an increasing trend (P>0.05).The yield per culture flask of the primary culture,secondary culture and tertiary culture were (1.12±0.15) × 106,(2.10±0.16)×106 and (1.04±0.16)×106,respectively.There was significant differences in the yield per culture flask between the secondary culture and the primary culture as well as the tertiary culture (all P<0.05),and there was no significant difference between the primary culture and the tertiary culture.However,the yield per culture flask of the tertiary culture had a decreasing trend (P>0.05).There was no difference among the three cultures in the growth curve and the expression of surface markers,and the osteogenic and adipogenic differentiation were all positive.Conclusions The P0 generation hpcMSCs isolated from a choriocarcinoma sample can be doubled by the three cultures compared with the primary culture,which can provide plenty stem cell source for the regenerative medicine.
2.Differentiation and Treatment of Essential Hypertension from the Perspective of Qi and Blood Disharmony
Hui XU ; Bin CHENG ; Nan JIANG ; Xiaofen HOU ; Changwu DONG
Journal of Traditional Chinese Medicine 2024;65(20):2155-2158
It is believed that qi and blood disharmony is the key pathogenesis of essential hypertension, for which mildly regulating qi and blood is recommended. According to the different pathological states and related causes of qi and blood disorders, essential hypertension can be divided into five syndrome types for differentiation and treatment. In terms of blood deficiency and liver constraint, it is recommended to nourish the blood and soften the liver, rectify qi to resolve constraint, using Xiao Yao Powder (逍遥散) or self-made Qihua Jieyu Decoction (七花解郁汤). For qi stagnation and blood stasis, the method of regulating qi and harmonizing blood, dissolving stasis and unblocking collaterals should be used, with self-made Guitao Tongluo Decoction (桂桃通络汤). For phlegm-dampness internal obstruction, it is recommended to move qi and promote urination, dissolve phlegm and eliminate dampness, using self-made Zhuanqi Sanzhuo Formula (转气散浊方). For binding of phlegm and stasis, dissolving phlegm and dispelling stasis, dredging the bowels and directing the turbid downward is advised, and self-made Sanren Tiaozhi Formula (三仁调脂方) can be used. In terms of deficiency of both qi and blood, it is recommended to boost qi and nourish blood, supplement deficiency and consolidate the root, using Gui Pi Decoction (归脾汤) or self-made Shenqi Zaizao Decoction (参芪再造汤).
3.Amplitude-Integrated Electroencephalography Predicts Outcome in Patients with Coma After Acute Brain Injury.
Wendong YOU ; Qilin TANG ; Xiang WU ; Junfeng FENG ; Qing MAO ; Guoyi GAO ; Jiyao JIANG
Neuroscience Bulletin 2018;34(4):639-646
Prognostication of coma patients after brain injury is important, yet challenging. In this study, we evaluated the predictive value of amplitude-integrated electroencephalography (aEEG) for neurological outcomes in coma patients. From January 2013 to January 2016, 128 coma patients after acute brain injury were prospectively enrolled and monitored with aEEG. The 6-month neurological outcome was evaluated using the Cerebral Performance Category Scale. aEEG monitoring commenced at a median of 7.5 days after coma onset. Continuous normal voltage predicted a good 6-month neurological outcome with a sensitivity of 93.6% and specificity of 85.2%. In contrast, continuous extremely low voltage, burst-suppression, or a flat tracing was correlated with poor 6-month neurological outcome with a sensitivity of 76.5% and specificity of 100%. In conclusion, aEEG is a promising predictor of 6-month neurological outcome for coma patients after acute brain injury.
Brain
;
physiopathology
;
Brain Injuries
;
complications
;
diagnosis
;
physiopathology
;
Coma
;
diagnosis
;
etiology
;
physiopathology
;
Electroencephalography
;
methods
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged
;
Neurophysiological Monitoring
;
methods
;
Prognosis
;
Prospective Studies
;
Sensitivity and Specificity
;
Severity of Illness Index
4.Comprehensive Proteomic Profiling of Patients' Tears Identifies Potential Biomarkers for the Traumatic Vegetative State.
Qilin TANG ; Chao ZHANG ; Xiang WU ; Wenbin DUAN ; Weiji WENG ; Junfeng FENG ; Qing MAO ; Shubin CHEN ; Jiyao JIANG ; Guoyi GAO
Neuroscience Bulletin 2018;34(4):626-638
The vegetative state is a complex condition with unclear mechanisms and limited diagnostic, prognostic, and therapeutic methods. In this study, we aimed to explore the proteomic profile of tears from patients in a traumatic vegetative state and identify potential diagnostic markers using tears-a body fluid that can be collected non-invasively. Using iTRAQ quantitative proteomic technology, in the discovery phase, tear samples collected from 16 patients in a traumatic vegetative state and 16 normal individuals were analyzed. Among 1080 identified tear proteins, 57 were upregulated and 15 were downregulated in the patients compared to the controls. Bioinformatics analysis revealed that the differentially-expressed proteins were mainly involved in the wound response and immune response signaling pathways. Furthermore, we verified the levels of 7 differentially-expressed proteins in tears from 50 traumatic vegetative state patients and 50 normal controls (including the samples used in the discovery phase) using ELISA. The results showed that this 7-protein panel had a high discrimination ability for traumatic vegetative state (area under the curve = 0.999). In summary, the altered tear proteomic profile identified in this study provides a basis for potential tear protein markers for diagnosis and prognosis of the traumatic vegetative state and also provides novel insights into the mechanisms of traumatic vegetative state.
Adult
;
Aged
;
Aged, 80 and over
;
Biomarkers
;
metabolism
;
Chromatography, Liquid
;
Enzyme-Linked Immunosorbent Assay
;
Eye Proteins
;
metabolism
;
Female
;
Humans
;
Male
;
Mass Spectrometry
;
Middle Aged
;
Persistent Vegetative State
;
metabolism
;
Proteome
;
Proteomics
;
ROC Curve
;
Tears
;
metabolism
;
Young Adult
5.Chinese expert consensus on the diagnosis and treatment of traumatic supraorbital fissure syndrome (version 2024)
Junyu WANG ; Hai JIN ; Danfeng ZHANG ; Rutong YU ; Mingkun YU ; Yijie MA ; Yue MA ; Ning WANG ; Chunhong WANG ; Chunhui WANG ; Qing WANG ; Xinyu WANG ; Xinjun WANG ; Hengli TIAN ; Xinhua TIAN ; Yijun BAO ; Hua FENG ; Wa DA ; Liquan LYU ; Haijun REN ; Jinfang LIU ; Guodong LIU ; Chunhui LIU ; Junwen GUAN ; Rongcai JIANG ; Yiming LI ; Lihong LI ; Zhenxing LI ; Jinglian LI ; Jun YANG ; Chaohua YANG ; Xiao BU ; Xuehai WU ; Li BIE ; Binghui QIU ; Yongming ZHANG ; Qingjiu ZHANG ; Bo ZHANG ; Xiangtong ZHANG ; Rongbin CHEN ; Chao LIN ; Hu JIN ; Weiming ZHENG ; Mingliang ZHAO ; Liang ZHAO ; Rong HU ; Jixin DUAN ; Jiemin YAO ; Hechun XIA ; Ye GU ; Tao QIAN ; Suokai QIAN ; Tao XU ; Guoyi GAO ; Xiaoping TANG ; Qibing HUANG ; Rong FU ; Jun KANG ; Guobiao LIANG ; Kaiwei HAN ; Zhenmin HAN ; Shuo HAN ; Jun PU ; Lijun HENG ; Junji WEI ; Lijun HOU
Chinese Journal of Trauma 2024;40(5):385-396
Traumatic supraorbital fissure syndrome (TSOFS) is a symptom complex caused by nerve entrapment in the supraorbital fissure after skull base trauma. If the compressed cranial nerve in the supraorbital fissure is not decompressed surgically, ptosis, diplopia and eye movement disorder may exist for a long time and seriously affect the patients′ quality of life. Since its overall incidence is not high, it is not familiarized with the majority of neurosurgeons and some TSOFS may be complicated with skull base vascular injury. If the supraorbital fissure surgery is performed without treatment of vascular injury, it may cause massive hemorrhage, and disability and even life-threatening in severe cases. At present, there is no consensus or guideline on the diagnosis and treatment of TSOFS that can be referred to both domestically and internationally. To improve the understanding of TSOFS among clinical physicians and establish standardized diagnosis and treatment plans, the Skull Base Trauma Group of the Neurorepair Professional Committee of the Chinese Medical Doctor Association, Neurotrauma Group of the Neurosurgery Branch of the Chinese Medical Association, Neurotrauma Group of the Traumatology Branch of the Chinese Medical Association, and Editorial Committee of Chinese Journal of Trauma organized relevant experts to formulate Chinese expert consensus on the diagnosis and treatment of traumatic supraorbital fissure syndrome ( version 2024) based on evidence of evidence-based medicine and clinical experience of diagnosis and treatment. This consensus puts forward 12 recommendations on the diagnosis, classification, treatment, efficacy evaluation and follow-up of TSOFS, aiming to provide references for neurosurgeons from hospitals of all levels to standardize the diagnosis and treatment of TSOFS.